{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:09:13Z","timestamp":1790370553201,"version":"4.1.0"},"reference-count":33,"publisher":"BMJ","issue":"8","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Med Genet"],"accepted":{"date-parts":[[2016,12,13]]},"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Following predictive testing for Huntington disease (HD), knowledge of one's carrier status may have consequences on disease onset. Our study aimed to address two questions. First, does knowledge of being a carrier of the pathological HD mutation trigger onset of the disease? Second, does this knowledge influence self-awareness and allow carriers to identify signs and symptoms of disease onset?<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Between 2012 and 2015, 75 HD mutation carriers were examined using the Unified Huntington's Disease Rating Scale (UHDRS) motor score. Onset estimation made with the disease burden score was compared with UHDRS findings. We collected qualitative data with questionnaires and semistructured interviews.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>38 women and 37 men, aged 43.7\u2005years\u00b110.5 (20\u201368), were interviewed after a mean delay between test and study interview of 10.5\u2005years\u00b14.7 (from 4 to 21\u2005years). Estimation of age at onset was 4.5\u00b18.5\u2005years earlier than data-derived age at onset. Participants were categorised according to their motor score: scores &lt;5 were premanifest (n=35), and scores &gt;5 were manifest carriers (n=40). Self-observation was a major preoccupation for all, independent of their clinical status (82% vs 74%, p=0.57). Among manifest carriers, 56% thought they showed symptoms, but only 33% felt ill. Interestingly, this was also observed in those without motor signs (20% and 9%). Being a mutation carrier did not significantly facilitate recognition of motor signs. Interviews with premanifest carriers allowed the burden of self-observation to be illustrated despite lack of motor signs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Estimating age at onset based on disease burden score may not be accurate. The transition to disease was experienced as an ambiguous or liminal experience. The view of mutation carriers is not always concordant with medical onset estimation, highlighting the difficulties involved in the concept of onset and its use as an outcome in future disease-modifying trials.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/jmedgenet-2016-104199","type":"journal-article","created":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T21:30:47Z","timestamp":1484343047000},"page":"511.1-520","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":20,"title":["A liminal stage after predictive testing for Huntington disease"],"prefix":"10.1136","volume":"54","author":[{"given":"Marcela","family":"Gargiulo","sequence":"first","affiliation":[{"name":"Laboratory of Clinical Psychology, Psychopathology and Psychoanalysis (PCPP, EA 4056), University Paris Descartes, Sorbonne Paris City, France"},{"name":"Institute of Myology, Piti\u00e9-Salp\u00eatri\u00e8re University Hospital, Paris, France"},{"name":"Department of Genetics, APHP, Piti\u00e9-Salp\u00eatri\u00e8re University Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2866-4330","authenticated-orcid":false,"given":"Sophie","family":"Tezenas du Montcel","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9s, UPMC Univ Paris 06 UMR_S1136; INSERM UMR_S 1136, Institut Pierre Louis d'Epid\u00e9miologie et de Sant\u00e9 Publique, Paris, France"},{"name":"Unit of Biostatistics, Assistance Publique\u2013H\u00f4pitaux de Paris, Groupe Hospitalier Piti\u00e9-Salp\u00eatri\u00e8re Charles-Foix, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie France","family":"Jutras","sequence":"additional","affiliation":[{"name":"Clinique Neuro Rive-Sud, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"Herson","sequence":"additional","affiliation":[{"name":"Institute of Myology, Piti\u00e9-Salp\u00eatri\u00e8re University Hospital, Paris, France"},{"name":"Department of Genetics, APHP, Piti\u00e9-Salp\u00eatri\u00e8re University Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Cazeneuve","sequence":"additional","affiliation":[{"name":"Department of Genetics, APHP, Piti\u00e9-Salp\u00eatri\u00e8re University Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Durr","sequence":"additional","affiliation":[{"name":"Department of Genetics, APHP, Piti\u00e9-Salp\u00eatri\u00e8re University Hospital, Paris, France"},{"name":"ICM (Brain and Spine Institute -Institut du Cerveau et de la Moelle Epini\u00e8re), Sorbonne Universit\u00e9s, UPMC Univ Paris 06 UMRS1127, and INSERM U1127, and CNRS UMR 7225 Piti\u00e9-Salp\u00eatri\u00e8re University Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,1,13]]},"reference":[{"key":"2025100511403767000_54.8.511.1","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1001\/jamaneurol.2016.2215","article-title":"Expanding the Spectrum of Genes Involved in Huntington Disease Using a Combined Clinical and Genetic Approach","volume":"73","author":"Mariani","year":"2016","journal-title":"JAMA Neurol"},{"key":"2025100511403767000_54.8.511.2","doi-asserted-by":"crossref","unstructured":"MacLeod R , Tibben A . Chapter 8: genetic counseling and testing. In: Bates G , Tabrizi S , Jones L , eds. Huntington's disease. 4th edn. New York: Oxford University Press, 2014: 165\u201381.","DOI":"10.1093\/med\/9780199929146.003.0008"},{"key":"2025100511403767000_54.8.511.3","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.neurol.2015.02.016","article-title":"Guidelines for presymptomatic testing for Huntington's disease: past, present and future in France","volume":"171","author":"Cl\u00e9ment","year":"2015","journal-title":"Rev Neurol (Paris)"},{"key":"2025100511403767000_54.8.511.4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1399-0004.2012.01900.x","article-title":"Recommendations for the predictive genetic test in Huntington's disease","volume":"83","author":"MacLeod","year":"2013","journal-title":"Clin Genet"},{"key":"2025100511403767000_54.8.511.5","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1212\/01.WNL.0000032255.75650.C2","article-title":"Presymptomatic testing in Huntington's disease and autosomal dominant cerebellar ataxias","volume":"59","author":"Goizet","year":"2002","journal-title":"Neurology"},{"key":"2025100511403767000_54.8.511.6","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ejhg.2012.147","article-title":"When access is an issue: exploring barriers to predictive testing for Huntington disease in British Columbia, Canada","volume":"21","author":"Hawkins","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"2025100511403767000_54.8.511.7","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2008.146"},{"key":"2025100511403767000_54.8.511.8","doi-asserted-by":"publisher","DOI":"10.1177\/0969733012452686"},{"key":"2025100511403767000_54.8.511.9","doi-asserted-by":"publisher","DOI":"10.1037\/0278-6133.23.2.189"},{"key":"2025100511403767000_54.8.511.10","doi-asserted-by":"publisher","DOI":"10.1177\/0891988710383573"},{"key":"2025100511403767000_54.8.511.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.11.034"},{"key":"2025100511403767000_54.8.511.12","unstructured":"Cazeneuve C , Durr A . Section 2: genetics of Huntington's disease\u2014Chapter 6: Genetic and molecular studies. In Bates G , Tabrizi S , Jones L , eds. Huntington's Disease. 4th edn. New York: Oxford University Press, 2014:109\u201330."},{"key":"2025100511403767000_54.8.511.13","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318249f683"},{"key":"2025100511403767000_54.8.511.14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2004.00241.x"},{"key":"2025100511403767000_54.8.511.15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/13648470301269","article-title":"Predictive genetic testing and the making of the pre-symptomatic person: Prognostic moralities amongst Huntington's-affected families","volume":"10","author":"Konrad","year":"2003","journal-title":"Anthropol Med"},{"key":"2025100511403767000_54.8.511.16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ajmg.c.30158","article-title":"You're one of us now\u2019: young people describe their experiences of predictive genetic testing for Huntington disease (HD) and familial adenomatous polyposis (FAP)","volume":"148C","author":"Duncan","year":"2008","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"2025100511403767000_54.8.511.17","doi-asserted-by":"publisher","DOI":"10.1007\/s10897-010-9329-6"},{"key":"2025100511403767000_54.8.511.18","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(11)70263-0"},{"key":"2025100511403767000_54.8.511.19","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70088-7"},{"key":"2025100511403767000_54.8.511.20","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70238-8"},{"key":"2025100511403767000_54.8.511.21","first-page":"S269","article-title":"Evaluating methods to enrich clinical trial populations in individuals at risk for Huntington's disease: the prospective Huntington at-risk observational study (PHAROS)","volume":"25","author":"Biglan","year":"2010","journal-title":"Mov Dis"},{"key":"2025100511403767000_54.8.511.22","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.neuropsychologia.2012.12.005","article-title":"Is non-recognition of choreic movements in Huntington disease always pathological?","volume":"51","author":"Justo","year":"2013","journal-title":"Neuropsychologia"},{"key":"2025100511403767000_54.8.511.23","first-page":"243","article-title":"Unawareness in brain disorders: a complex and multifaceted phenomenon","volume":"7","author":"Derouesn\u00e9","year":"2009","journal-title":"Psychol Neuropsychiatr Vieil"},{"key":"2025100511403767000_54.8.511.24","doi-asserted-by":"crossref","first-page":"RRN1258","DOI":"10.1371\/currents.RRN1258","article-title":"Age-at-onset in Huntington disease","volume":"3","author":"Orth","year":"2011","journal-title":"PLoS Curr"},{"key":"2025100511403767000_54.8.511.25","doi-asserted-by":"crossref","first-page":"375935","DOI":"10.1155\/2012\/375935","article-title":"Predicting disease onset from mutation status using proband and relative data with applications to huntington's disease","volume":"2012","author":"Chen","year":"2012","journal-title":"J Probab Stat"},{"key":"2025100511403767000_54.8.511.26","first-page":"5","article-title":"Is a motor criterion essential for the diagnosis of clinical huntington disease? Version 2","volume":"11","author":"Loy","year":"2013","journal-title":"PLoS Curr"},{"key":"2025100511403767000_54.8.511.27","first-page":"707","article-title":"Les rites de passage (in French). Paris: \u00c9mile Nourry 1909. Lay summary\u2014Review by Starr F","volume":"15","author":"Van Gennep","year":"1910","journal-title":"Am J Sociol"},{"key":"2025100511403767000_54.8.511.28","doi-asserted-by":"publisher","DOI":"10.1076\/jmep.27.6.651.13793"},{"key":"2025100511403767000_54.8.511.29","first-page":"76","article-title":"Introduction g\u00e9n\u00e9rale; De la sant\u00e9 \u00e0 la maladie; La douleur dans les maladies; O\u00f9 va la m\u00e9decine","volume":"6","author":"Leriche","year":"1936","journal-title":"Encyclop Fr"},{"key":"2025100511403767000_54.8.511.30","doi-asserted-by":"crossref","unstructured":"Canguilhem G . The Normal and the Pathological. Dordrecht, Holland: D. Reidel Publishing Company, 1978:227.","DOI":"10.1007\/978-94-009-9853-7"},{"key":"2025100511403767000_54.8.511.31","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.69.5.574"},{"key":"2025100511403767000_54.8.511.32","unstructured":"Canguilhem G . Health: popular concept and philosophical question. In: Writings on medicine. Transl. Geroulanos S , Meyers T , eds. New York: Fordham University Press, 2012: 43."},{"key":"2025100511403767000_54.8.511.33","unstructured":"Canguilhem G . La sant\u00e9: concept vulgaire et question philosophique, conf\u00e9rence tenue \u00e0 Strasbourg en 1988. In Ecrits sur la m\u00e9decine. Paris: Seuil, 2002: 63."}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmedgenet-2016-104199","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T18:40:46Z","timestamp":1759689646000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmedgenet-2016-104199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,13]]},"references-count":33,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,7,25]]},"published-print":{"date-parts":[[2017,8]]}},"alternative-id":["10.1136\/jmedgenet-2016-104199"],"URL":"https:\/\/doi.org\/10.1136\/jmedgenet-2016-104199","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"value":"0022-2593","type":"print"},{"value":"1468-6244","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,13]]}}}